Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
23.88
+1.81 (8.20%)
At close: Mar 9, 2026, 4:00 PM EDT
24.70
+0.82 (3.43%)
After-hours: Mar 9, 2026, 7:37 PM EDT
Syndax Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -285.42 | -318.76 | -209.36 | -149.34 | 24.93 | |
| Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.03 | 0.04 | |
| Other Amortization | 0.23 | 0.03 | - | - | - | |
| Loss (Gain) From Sale of Investments | -10.75 | -13.47 | -14.8 | -3.38 | 0.64 | |
| Stock-Based Compensation | 47.5 | 43.03 | 30.95 | 16.02 | 13.32 | |
| Provision & Write-off of Bad Debts | 3.67 | - | - | - | - | |
| Other Operating Activities | 1.11 | 0.99 | 0.74 | 1.34 | -0.2 | |
| Change in Accounts Receivable | -30.39 | -7.6 | - | - | - | |
| Change in Inventory | -32.09 | -0.37 | - | - | - | |
| Change in Accounts Payable | 4.95 | 1.67 | 5.61 | -1.32 | 2.16 | |
| Change in Unearned Revenue | - | - | - | - | -13.13 | |
| Change in Other Net Operating Assets | -21.79 | 19.57 | 26.25 | 2.98 | 1.38 | |
| Operating Cash Flow | -322.98 | -274.9 | -160.6 | -133.68 | 29.13 | |
| Capital Expenditures | -0.19 | - | - | - | -0.13 | |
| Sale of Property, Plant & Equipment | - | - | - | 0.23 | - | |
| Investment in Securities | 290.22 | -219.78 | 117.61 | -186.41 | -40.74 | |
| Investing Cash Flow | 290.04 | -219.78 | 117.61 | -186.19 | -40.87 | |
| Long-Term Debt Repaid | - | - | - | -21 | - | |
| Net Debt Issued (Repaid) | - | - | - | -21 | - | |
| Issuance of Common Stock | 13.68 | 9.72 | 278.18 | 193.25 | 117.89 | |
| Other Financing Activities | - | 343.65 | -14.04 | - | 0.58 | |
| Financing Cash Flow | 13.68 | 353.37 | 264.13 | 172.25 | 118.46 | |
| Net Cash Flow | -19.27 | -141.31 | 221.14 | -147.61 | 106.72 | |
| Free Cash Flow | -323.17 | -274.9 | -160.6 | -133.68 | 29 | |
| Free Cash Flow Margin | -187.50% | -1160.91% | - | - | 20.76% | |
| Free Cash Flow Per Share | -3.73 | -3.21 | -2.28 | -2.20 | 0.54 | |
| Cash Interest Paid | - | - | - | 2.06 | 2 | |
| Levered Free Cash Flow | -210.05 | -155.45 | -82.37 | -76.27 | 32.03 | |
| Unlevered Free Cash Flow | -189.17 | -152.4 | -82.24 | -74.31 | 33.22 | |
| Change in Working Capital | -79.32 | 13.27 | 31.86 | 1.66 | -9.6 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.